S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
NYSEARCA:IDNA

iShares Genomics Immunology and Healthcare ETF Stock Forecast, Price & News

$53.50
-1.71 (-3.10 %)
(As of 09/24/2021 12:00 AM ET)
Add
Today's Range
$53.47
$54.81
50-Day Range
$48.41
$55.47
52-Week Range
$37.44
$55.55
Volume60,480 shs
Average Volume72,711 shs
Market Capitalization$369.15 million
P/E RatioN/A
Dividend Yield0.16%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive IDNA News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Genomics Immunology and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer iShares
Fund NameiShares Genomics Immunology and Healthcare ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:IDNA
Inception Date6/11/2019
Fund ManagerRachel Aguirre, Jennifer Hsui, Alan Mason, Greg Savage, Amy Whitelaw
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkNYSE FactSet Global Genomics and Immuno Biopharma Index
CategoryStrategy
FocusTheme
Development LevelBlended Development
RegionGlobal

Fund Statistics

Assets Under Management$368.47 million
Average Daily Volume$0.00
Discount/Premium0.00%

ETF Expenses

Management Fee0.47%
Other Expenses0.00%
Total Expenses0.47%
Fee Waiver0.00%
Net Expenses0.47%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market Maker

Geographic Exposure of IDNA

Currency Exposure of IDNA

Sector Exposure of IDNA

Industry Exposure of IDNA

speech bubbles
speech bubbles











iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Frequently Asked Questions

What stocks does MarketBeat like better than iShares Genomics Immunology and Healthcare ETF?

Wall Street analysts have given iShares Genomics Immunology and Healthcare ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but iShares Genomics Immunology and Healthcare ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has iShares Genomics Immunology and Healthcare ETF's stock been impacted by Coronavirus (COVID-19)?

iShares Genomics Immunology and Healthcare ETF's stock was trading at $26.77 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, IDNA stock has increased by 99.9% and is now trading at $53.50.
View which stocks have been most impacted by COVID-19
.

Is iShares Genomics Immunology and Healthcare ETF a good dividend stock?

iShares Genomics Immunology and Healthcare ETF pays an annual dividend of $0.09 per share and currently has a dividend yield of 0.16%.
View iShares Genomics Immunology and Healthcare ETF's dividend history.

What other stocks do shareholders of iShares Genomics Immunology and Healthcare ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Genomics Immunology and Healthcare ETF investors own include Pfizer (PFE), Gilead Sciences (GILD), Intel (INTC), AbbVie (ABBV), Inovio Pharmaceuticals (INO), Novavax (NVAX), Canadian Natural Resources (CNQ), QUALCOMM (QCOM), SPDR S&P Biotech ETF (XBI) and Bristol-Myers Squibb (BMY).

What is iShares Genomics Immunology and Healthcare ETF's stock symbol?

iShares Genomics Immunology and Healthcare ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "IDNA."

Who are iShares Genomics Immunology and Healthcare ETF's major shareholders?

iShares Genomics Immunology and Healthcare ETF's stock is owned by a variety of institutional and retail investors. Top institutional investors include Wealthcare Advisory Partners LLC (1.68%), Baird Financial Group Inc. (0.72%), Sigma Planning Corp (0.09%), Flow Traders U.S. LLC (0.08%), Patriot Financial Group Insurance Agency LLC (0.08%) and Wealthcare Capital Management LLC (0.08%).

Which institutional investors are selling iShares Genomics Immunology and Healthcare ETF stock?

IDNA stock was sold by a variety of institutional investors in the last quarter, including Flow Traders U.S. LLC, and Sigma Planning Corp.

Which institutional investors are buying iShares Genomics Immunology and Healthcare ETF stock?

IDNA stock was purchased by a variety of institutional investors in the last quarter, including Wealthcare Advisory Partners LLC, Patriot Financial Group Insurance Agency LLC, Baird Financial Group Inc., and Wealthcare Capital Management LLC.

How do I buy shares of iShares Genomics Immunology and Healthcare ETF?

Shares of IDNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iShares Genomics Immunology and Healthcare ETF's stock price today?

One share of IDNA stock can currently be purchased for approximately $53.50.

How much money does iShares Genomics Immunology and Healthcare ETF make?

iShares Genomics Immunology and Healthcare ETF has a market capitalization of $369.15 million.


This page was last updated on 9/26/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.